A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

NCT05033132 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was never initiated.

Conditions

Cervical Cancer

Interventions

DRUG: Balstilimab
DRUG: Balstilimab + Zalifrelimab

Sponsor

Agenus Inc.

Collaborators

[object Object]